GPX4-IN-6
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-155664-5MG | 5 mg | 115,00 | Add | |
| HY-155664-1ML | 10mM/1mL | 126,00 | Add | |
| HY-155664-10MG | 10 mg | 165,00 | Add | |
| HY-155664-25MG | 25 mg | 304,00 | Add | |
| HY-155664-50MG | 50 mg | 482,00 | Add | |
| HY-155664-100MG | 100 mg | 749,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
GPX4-IN-6 (Compound C25) is a GPX4 covalent inhibitor with an IC50 value of 0.13 μM. GPX4-IN-6 (Compound C25) can induce ferroptosis for the research of triple-negative breast cancer (TNBC) [1].
| Category | Inhibitor |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Apoptosis,Metabolic Enzyme/Protease |
| Format | Solubility: DMSO : 50 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.65% |
| Molecular Formula | C18H17BrFNO5 |
| Molecular Weight | 426.23 |
| CAS-Number | 2922824-07-3 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
